Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sack

Showing results (211-220 of 245) with videos related to

Pageof 25
Sort By:
Biorxiv : the Preprint Server for Biology|December 18, 2023
Integrated omics analysis unveils a DNA damage response to neurogenic injuryAli Hashemi Gheinani, Bryan S Sack, Alex Bigger-Allen, et al.
JCI Insight|May 8, 2025
Multiomics analysis unveils an inosine-sensitive DNA damage response in neurogenic bladder after spinal cord injuryAli Hashemi Gheinani, Bryan S Sack, Alexander Bigger-Allen, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2013
The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding modeStephen T Wrobleski, Shuqun Lin, T G Murali Dhar, et al.
Annals of the American Thoracic Society|April 3, 2024
Air Pollution Exposure and Interstitial Lung Features in SPIROMICS Participants with Chronic Obstructive Pulmonary DiseaseNicolas A Baddour, Laura M Paulin, Amanda J Gassett, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2017
Discovery of highly potent, selective, covalent inhibitors of JAK3James Kempson, Damaso Ovalle, Junqing Guo, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2008
The discovery of (R)-2-(sec-butylamino)-N-(2-methyl-5-(methylcarbamoyl)phenyl) thiazole-5-carboxamide (BMS-640994)-A potent and efficacious p38alpha MAP kinase inhibitorJohn Hynes, Hong Wu, Sidney Pitt, et al.
Medchemcomm|August 16, 2018
Identification of imidazo[1,2-<i>b</i>]pyridazine TYK2 pseudokinase ligands as potent and selective allosteric inhibitors of TYK2 signallingR Moslin, D Gardner, J Santella, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Novel Tricyclic Pyroglutamide Derivatives as Potent RORγt Inverse Agonists Identified using a Virtual Screening ApproachQingjie Liu, Douglas G Batt, Carolyn A Weigelt, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2017
Discovery of 7-(3-(piperazin-1-yl)phenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives as highly potent and selective PI3Kδ inhibitorsLan-Ying Qin, Zheming Ruan, Robert J Cherney, et al.
Bioorganic & Medicinal Chemistry Letters|July 2, 2019
Identification of potent, selective and orally bioavailable phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfone analogues as RORγt inverse agonistsZhonghui Lu, James J-W Duan, Haiyun Xiao, et al.
Pageof 25

Showing results (211-220 of 245) with videos related to

Sort By:
Pageof 25
Biorxiv : the Preprint Server for Biology|December 18, 2023
Integrated omics analysis unveils a DNA damage response to neurogenic injuryAli Hashemi Gheinani, Bryan S Sack, Alex Bigger-Allen, et al.
JCI Insight|May 8, 2025
Multiomics analysis unveils an inosine-sensitive DNA damage response in neurogenic bladder after spinal cord injuryAli Hashemi Gheinani, Bryan S Sack, Alexander Bigger-Allen, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2013
The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding modeStephen T Wrobleski, Shuqun Lin, T G Murali Dhar, et al.
Annals of the American Thoracic Society|April 3, 2024
Air Pollution Exposure and Interstitial Lung Features in SPIROMICS Participants with Chronic Obstructive Pulmonary DiseaseNicolas A Baddour, Laura M Paulin, Amanda J Gassett, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2017
Discovery of highly potent, selective, covalent inhibitors of JAK3James Kempson, Damaso Ovalle, Junqing Guo, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2008
The discovery of (R)-2-(sec-butylamino)-N-(2-methyl-5-(methylcarbamoyl)phenyl) thiazole-5-carboxamide (BMS-640994)-A potent and efficacious p38alpha MAP kinase inhibitorJohn Hynes, Hong Wu, Sidney Pitt, et al.
Medchemcomm|August 16, 2018
Identification of imidazo[1,2-<i>b</i>]pyridazine TYK2 pseudokinase ligands as potent and selective allosteric inhibitors of TYK2 signallingR Moslin, D Gardner, J Santella, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Novel Tricyclic Pyroglutamide Derivatives as Potent RORγt Inverse Agonists Identified using a Virtual Screening ApproachQingjie Liu, Douglas G Batt, Carolyn A Weigelt, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2017
Discovery of 7-(3-(piperazin-1-yl)phenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives as highly potent and selective PI3Kδ inhibitorsLan-Ying Qin, Zheming Ruan, Robert J Cherney, et al.
Bioorganic & Medicinal Chemistry Letters|July 2, 2019
Identification of potent, selective and orally bioavailable phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfone analogues as RORγt inverse agonistsZhonghui Lu, James J-W Duan, Haiyun Xiao, et al.
Pageof 25